
PUBLICATIONs

247. “Engineering gene therapy across anatomical, biological and spatiotemporal barriers in high-grade gliomas”
...
L.D.D Filippo, J.L. Duarte, G.A. de Paula, Z. Tian, A.C.L. de Almeida, Catarina Martins, Diana Peixoto, J. H. Azambuja, S. Yerneni1*, M. Chorilli* and João Conde*

246. “Pan-cancer analysis of fibroblasts and macrophages defines a prognostic stromal-immune axis in breast cancer”
...
B. Xiao, L. Zhou, J. Yao, X. Tang, C. Yin, B. Yang, F. Zhao, Y. Zhou, J. Kuang, W. Jin, V. Balan, R. Mall, A. K. Barui, M. S., S. Liu, Y. Pan, João Conde and Z. Jiang.

245. “AI-driven multitarget drug design for overcoming therapeutic resistance in precision oncology”
...
Z. Xu, Y. Li, F. Zhao, Y. Zhou, J. Kuang, D. Zhao, W. Li, C. Liu*, João Conde* and S. Liu*

244. “Global, regional, and national burden of smoking tobacco use and attributable disease in 204 countries and territories, 1990–2023: a systematic analysis from the Global Burden of Disease Study 2023”
...
João Conde & GBD Collaborators - Global Burden of Disease (GBD) Consortium

243. “Drug-tolerant persister states as a clinically actionable origin of cancer therapy failure”
...
...

242. “Global, regional, and national burden of soft tissue sarcomas and other extraosseous sarcomas, 1990-2023 with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023”
...
João Conde & GBD Collaborators - Global Burden of Disease (GBD) Consortium

241. “WNK3 activates nuclear accumulation of GLI1 and recruits immunosuppressive CXCR2+ PMN-MDSCs to reduce CD8+ T cell cytotoxicity and promote colorectal tumorigenesis”
...
J. Kuang, Y. Zhou, F. Zhao, C. Lin, Z. Qin, Q. Jiang, H. Deng, X. Guo, Q. Zhang, João Conde*, K. Zhu*, M. Tian*, P. Zhao* and J. Li*

240. “A Sprayable Sodium/Tannic Acid-Lipoic acid Hydrogel with Immunomodulatory and Pro-Adhesive Properties for Enhanced Burn Wound Regeneration”
...
...

239. “Global, regional, and national burden of lung cancer and associated risk factors, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023”
...
João Conde & GBD Collaborators - Global Burden of Disease (GBD) Consortium

238. “miRNA signature variability across multiple biological models exposes subtype and 3D compactness as dominant barriers to miR nanodelivery”
...
Jhenifer Oliveira, Mariana Pereira, M. Soares, R. Murphy, A.R. Grosso, Bárbara B. Mendes and João Conde*

237. “Global, regional, and national burden of malignant neoplasm of bone and articular cartilage from 1990 to 2023 and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023”
...
João Conde & GBD Collaborators - Global Burden of Disease (GBD) Consortium

236. “pH-triggered gold-PNA nanoclusters reverse miR-155-driven radioresistance in breast cancer”
...
Y. Jiang, Y. Zhang, L. Zhou, H. Yang, H. Gao, W. Hai, C. Zhang, J. Yao, R. Mall, João Conde*, S. Li*, B. Li* and M. Zhang*

235. “Cancer survivorship burden is rising worldwide with widening inequalities”
...
João Conde & GBD Collaborators - Global Burden of Disease (GBD) Consortium

234. “Spatiotemporal thermal gating of a soft nanocomposite enables on demand in situ tumour RNA interference with non-ablative hyperthermia”
...
Catarina F. Martins, Diana Peixoto, C. García-Astrain, T. Pinheiro, Bárbara B. Mendes, Jhenifer Oliveira, L.M. Liz-Marzán and João Conde*

233. “Global, regional, and national burden of colon and rectum cancer from 1990 to 2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023”
...
João Conde & GBD Collaborators - Global Burden of Disease (GBD) Consortium

232. “Engineering hybrid cell membrane nanovesicles and biomimetic nanoparticles for cancer diagnosis and therapy”
...
Diana Peixoto, F. Veiga, A. Concheiro, A.C. Paiva-Santos, C. Alvarez-Lorenzo* and João Conde*

231. “Global, regional, and national burden of stomach cancer from 1990 to 2023 and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023”
...
João Conde & GBD Collaborators - Global Burden of Disease (GBD) Consortium

230. “A hybrid large language model framework for multi-disease risk stratification and earlyclinical triage from routine blood counts”
...
C. Yin, Z. Wang, F. Zhao, B. Yang, H. Zhou, C. Li, G. Fan, Y. He, B. Song, Z. Sun, H. Wang, J. Kuang, Manimurugan S., A.K. Barui, J. Zhao*, Y. Zhou*, D Xin*, P. Han*, João Conde* and S. Lou*

229. “Mapping trends in extended routine childhood vaccination in 101 countries”
...
João Conde & GBD Collaborators - Global Burden of Disease (GBD) Consortium

228. “Atomically defined heteronuclear diatomic sites in porous Janus MOF enable multi enzyme nanozyme catalysis for tumour therapy”
...
M. Jiang, H. Huang, M. Tan, J. Deng, Z. Huang, C. Ma, P. Ma, Y. Ye, Y. Su, S. Liang, Y. Zhao, C. Li, Z. Wu, Q. Zhang, G. Feng, Q. Jia, Y. Li, Z. Liu, A. Liu, R. Wei, T. Wang, R. Alarcón Rodríguez, Z. Bo, J. Zhao, Y. Tian, M. Ashrafizadeh, João Conde, K. Fan, R. Liang, J. Zhong and L. Zheng

227. “Targeting EP2 overcomes osimertinib resistance through metabolic and inflammatory reprogramming in non-small cell lung cancer”
...
H. Yu, J. Pan, J. Wei, Y. Wu, Z. Wang, Q. Chen, M. Ashrafizadeh, João Conde*, Y. Sun*, Y. Pan* and X. Qian*

226. “Global, regional, and national prevalence of second-hand smoke and attributable disease burden in 204 countries and territories, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023”
...
João Conde & GBD Collaborators - Global Burden of Disease (GBD) Consortium

225. “In situ-forming hydrogel for spatiotemporally controlled delivery of homologous cancer cell membrane-coated micelles toward metastatic pancreatic cancer therapy”
...
Diana Peixoto, Catarina F. Martins, P. Diaz-Rodriguez, F. Veiga, A. Concheiro, A.C. Paiva-Santos, C. Alvarez-Lorenzo* and João Conde*

224. “CD52 is a clinically relevant regulator of tumor-immune interactions in lymph node metastasis”
...
Y. Xi, L. Li, C. Xu, F. Zhao, F. Ye, M. Yuan, C. Ye, L. Jiang, Y. Huang, J. Zhang, W. Shen, J. Kuang, A.K. Barui, M. Shanmuganathan, Y. Zhou*, H. Chen*, João Conde* and B. Yu*

223. “3D bioprinted endometriosis model with fibrin bioinks for nanoparticle-Photo-Thermal Therapy evaluation”
...
Cristina Volpini, G. Guagliano, N. Bloise, Barbara B. Mendes, F.B. Vangosa, P. Petrini, B. Gardella, S. Ferrero, João Conde, P. Minzioni and L. Visai*

222. “Imaging-guided NIR-II theranostic nanoprobes disable m6A reader-stabilized resistance mRNAs in pancreatic cancer”
...
J. Zhu, X. Wang, Y. Xu, S. Fang, K. Zhao, Z. Yu, X. Xu, J. Zhang, M. Zhang, B. Gan, J. Lu, R. Zhou, Y. Chen, J. Sun, João Conde* and S. Zheng*

221. “Global, regional and national burden of cervical cancer and associated risk factors from 1990 to 2023 and forecasts to 2050: A systematic analysis for the Global Burden of Disease Study 2023”
...
João Conde & GBD Collaborators - Global Burden of Disease (GBD) Consortium

220. “Machine learning prediction of phenotypic toxicity to liposomal formulations via pre-dose metabolomics”
...
M. Zhao, , Y. Wang, Y. Xiao, G. Hu, Y. Zou, J. Li, L. Zhao, X. Ye, H. Liu, João Conde*, Y. Zhao* C. Yin* and H. Meng*





